Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 92.1729
Recommendation STRONG BUY
P/E 80.50
ROE 100.00 %
Capitalization 328,316,720,000 $
Dividend Yield 1.05 %
P/S 14.36
AII Position 41
P/E Position 707
ROE Position 29
Capitalization Position 11
Dividend Yield Position 510
Sales 22,859,000,000 $
10-Year Average Earnings 4,078,250,000 $
Shares Outstanding 1,637,000,000
Equity 3,945,000,000 $
Dividend per Share 2.1 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $
2008 12 14,179,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $
2008 12 4,058,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:

Mar 21, 2017
Goldman Says These Dividend Stocks Will Do Well Even With the Fed Hiking Rates
WHR, HD, LOW, PHM, MO, RAI, ADM, CVS, MJN, VLO, PSX, MPC, TSO, LM, HBAN, KEY, MMC, MS, BEN, UNM, ABBV, PFE, AMGN, CAH, MDT, ABT, DGX, BA, NLSN, ITW, HON, IR, CSCO, XRX, HPQ, IBM, TXN, MSI, MSFT, GLW...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
8.6 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
Positive EPS Surprises for First Quarter of ’13 for S&P 500
62 1.6 Mar 4/30 EQR Equity Residential 0.64 0.61 4.9 0.63 1.6 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/25 CELG Celgene Corp ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
4.8 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
May 16, 2013
And the Winner of the Top Student-Run Investment Fund Is ...
Apache (APA), -15.42 percent UnitedHealth Group (UNH), -2.52 percent AbbVie (ABBV), -2.39 percent FIXED INCOME First Place: Stetson University...
Nov 14, 2014
Maverick Capital Ltd Holdings in 3rd Quarter: 13F Alert
Plc-Series C LBTYK US 279,296,113 6,809,609 238,560 AbbVie Inc ABBV US 272,833,865 4,723,578 1,488,445 CBS Corp-Class B Non Voting CBS US 258,296...
Feb 14, 2013
SAC Capital Advisors Holdings in 4th Quarter: 13F Alert
Alcatel-Lucent-Sponsored ADR ALU US 54,244,194 39,024,600 39,024,600 AbbVie Inc ABBV US 51,877,221 1,518,654 1,518,654 Analog Devices Inc ADI US 47,426...
Dec 10, 2012
Abbott Spinoff AbbVie Begins Trading to Determine Value
percent to $30.30 at 4 p.m. New York time. AbbVie when-issued shares, trading under the ticker ABBV-W, opened at $37 and fell 5.4 percent to $35. The secondary market for the when-issued shares...
May 3, 2013
S&P 500 Stocks Biggest Weekly Changes in Target Price
44.58 42.09 3.526 THC TENET HEALTHCAR 5.90 14 49.18 46.44 4.043 ABBV ABBVIE INC 5.85 6 46.22 43.67 3.800 TWX TIME WARNER INC 5...
Jun 12, 2013
Higher, Lower, Unchanged and Reversed EPS for S&P 500
6.7 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/18 AN AutoNation Inc ...


Google News for ABBVIE:

Nasdaq - 5 days ago
AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?
AbbVie Inc. ABBV shares hit a 52-week high of $71.12 on Friday before eventually closing at $71.05. In fact, shares of the company are up ...
Seeking Alpha - 3 days ago
AbbVie: A Wonderful Company But At What Price?
AbbVie (NYSE:ABBV) is likely to replace the lost earnings and it has plenty of time to do so. Furthermore, concerns about the company's debt ...
Endpoints News
AbbVie (ABBV) Provided a Positive Opinion for MAVIRET ...
AbbVie (ABBV) Provided a Positive Opinion for MAVIRET (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major ...
StreetInsider.com - 1 day ago
AbbVie (ABBV) Announced Positive Phase III RA Candidate Data
AbbVie Inc. ABBV announced positive top-line results from a phase III study on rheumatoid arthritis candidate, upadacitinib (ABT-494).
Nasdaq - 8 Jun 2017
Why AbbVie Is A 'Trump Stock'
AbbVie is a "Trump Stock" which could return a lot of money to ... AbbVie Inc (NYSE:ABBV), the pharmaceutical company best known for ...
The Pharma Letter (registration)
AbbVie's Eagerly Anticipated Followup to Humira Is Coming: What ...
For years, AbbVie's (NYSE:ABBV) powerhouse product Humira has held the top-dog position of best-selling drug in the world. In 2016, this ...
Smаrt Stоck Nеws
AbbVie (ABBV) Enters Collaboration on Oral Immunoproteasome ...
AbbVie (NYSE: ABBV) and Principia Biopharma entered a collaboration for the development of oral immunoproteasome inhibitors.
Seeking Alpha - 14 Jun 2017
AbbVie (ABBV) Says Upadacitinib (ABT-494) Met All Primary and ...
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced positive top-line results from the Phase 3 SELECT-NEXT ...
Motley Fool
Price Alert: AbbVie Inc (NYSE:ABBV) Stock Nears Resistance ...
Price Alert: AbbVie Inc (NYSE:ABBV) has now crossed into technical strength -- watch the technical oscillators for momentum gaps.
Market Realist
Buy or Sell? Average Brokerage Ratings on Visa Inc. (V), AbbVie Inc ...
AbbVie Inc. (NYSE:ABBV) ended its day at $71.34 with the rising stream of 0.17% and its total traded volume was 6.09 million shares more than ...


Back